FTC settles with Amgen over $27.8 billion takeover of Horizon Therapeutics
September 01, 2023 at 10:01 AM EDT
The Federal Trade Commission reached a deal with Amgen to approve its $27.8 billion acquisition of Horizon Therapeutics plc the agency announced Friday.
